ArticleJournal of virology1996
Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy.
Article in Journal of virology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 25 citations in OpenAlex.
- Recent advances in gene therapy: genetic bullets to the root of the problem.Clinical and experimental medicine · 2023Review
- PD 404,182 is a virocidal small molecule that disrupts hepatitis C virus and human immunodeficiency virus.Antimicrobial agents and chemotherapy · 2012Article
- Article
- Article
- Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model.Cancer research · 2007Article
- Is gene therapy a good therapeutic approach for HIV-positive patients?Genetic vaccines and therapy · 2007Article
- Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses.Journal of virology · 2006Article
- Determinants of high titer in recombinant porcine endogenous retroviruses.Journal of virology · 2004Article
- Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process.Journal of virology · 2003Article
- Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors.Human gene therapy · 2003Article
- Nonreciprocal pseudotyping: murine leukemia virus proteins cannot efficiently package spleen necrosis virus-based vector RNA.Journal of virology · 1998Article
- Construction and characterization of a hybrid mouse mammary tumor virus/murine leukemia virus-based retroviral vector.Journal of virology · 1998Article
- Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1.Journal of virology · 1998Article
- Efficient infection mediated by viral receptors incorporated into retroviral particles.Journal of virology · 1998Article
- Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control.Proceedings of the National Academy of Sciences of the United States of America · 1997Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We have constructed new murine leukemia virus (MLV)-based vectors (TIN vectors) which, following integration, contain human immunodeficiency virus (HIV) type 1 U3 and R sequences in place of the MLV U3 and R regions. This provides, for the first time, single transcriptional unit retroviral vectors under the control of Tat. TIN vectors have several advantages for anti-HIV gene therapy applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.